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D espite major therapeutic advances, the public healthburden associated with coronary heart disease (CHD)
remains enormous with approximately 525 000 people pre-
dicted to have a new myocardial infarction (MI) in 2013,
15.4 million estimated to be living with CHD in 2013, and
1 346 000 people hospitalized in 2009 for CHD.1
There are a variety of ways to measure the population
impact of a disease including prevalence, associated morbid-
ity and mortality, quality of life, health care utilization, and
economic costs, and one of the most critical is disease
incidence. From a surveillance perspective in the United
States, the national vital statistics data system provides
information about the death rate for CHD, various national
data systems provide estimates of hospitalizations for CHD
and outpatient visits for CHD, and national data systems
provide data about levels of risk factors for CHD. The data
systems allowing for estimates of prevalent CHD are less
robust as they rely primarily on self-reported information.
A particularly glaring gap in our knowledge base has been
the lack of nationally representative data to measure the
incidence of CHD. Measuring incidence of a disease is
particularly salient because incidence (1) is a key measure in
helping to define the burden of a disease and identify high-risk
populations, (2) provides valuable information in helping
decision makers set public health priorities, and (3) is a more
relevant measure to assess the collective influence of risk
factors in a population than prevalence. Consequently,
tracking incidence of a disease in populations can: (1) yield
timely data about potentially unfavorable changes in inci-
dence that may prompt a search for explanations and
corrective actions to redirect the course of a disease in a
population, (2) provide valuable feedback in assessing efforts
to control a disease, and (3) generate useful information for
updating priorities regarding health promotion and disease
prevention. The reasons why a national surveillance system to
track CHD incidence in the United States has never been
developed are not entirely clear but may relate to the cost and
complexity of implementing such a system.
Our objective is to review the fragmented data thatmay have
bearing on incidence of CHD in the United States. Because
national data about incident CHD are not readily available, we
will examine various facets of CHD epidemiology—including
mortality, hospitalizations and case-fatality, prevalence, risk
factors, and predicted risk—that may provide insights about
national trends in the incidence of CHD. Incidence, preva-
lence, and mortality are interrelated,2,3 and, hence, we will
explore data for the latter two important population surveil-
lance parameters. Declining mortality rates have been postu-
lated as possible evidence for declining incidence rates, and,
therefore, we examine published trends in mortality as well as
in case-fatality rates that have bearing on overall mortality
rates from CHD. Furthermore, trends in hospitalizations for MI
have often been used as a surrogate measure for trends in
incidence of this condition, and consequently, we review
national and regional data on this topic. Because the sum
total of risk factors for CHD drive the incidence of this
disease, we assess trends in individual risk factors as well as
predicted risk calculated from major CHD risk factors. Finally,
we review regional data about trends in CHD incidence from
community surveillance and cohort studies.
Mortality
The category “diseases of the heart” has long been and
continues to be the leading cause of death in the United
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CONTEMPORARY REVIEW
States based on data from death certificates.4 After
increasing during the first part of the 20th century, the
mortality rate attributed to CHD peaked during the late
1960s and reversed course starting a prolonged and
continuing decline.5,6 From 1980 through 2009, age-
adjusted CHD mortality has decreased by 66% among men
and 67% among women (Figure 1). Furthermore, age-
adjusted rates decreased by 60% among African American
women, 57% among African American men, 68% among
white women, and 67% among white men (Figure 2). CHD
mortality was defined as International Classification of
Diseases (ICD)-9 codes 410-414 and 429.2 or ICD-10 codes
I20-I25. Regional studies such as the Framingham Heart
Study, the Minnesota Heart Survey, Honolulu Heart Program,
and the Atherosclerosis Risk in Communities Study (ARIC)
also described declining rates of CHD mortality.7–11 The
factors contributing to the decline have been debated, and a
combination of treatment and improvements in population
levels of risk factors for CHD has been credited with
lowering the CHD mortality rate.12–17 The declining mortality
rates raised the prospect of declining incidence rates.
Because mortality rates are subject to a number of
influences such as disease severity, case fatality, changes
in risk factors, improved treatment, and incident or new
cases,18 declining mortality rates alone cannot automatically
be equated with declining incidence rates.
Hospitalizations
Several large data sets have provided information about
trends in hospitalizations for MI (Table 1).
Based on the Acute Care Tracker data base, a proprietary
administrative database that included 458 US hospitals,
rates of hospitalization for MI based on principal diagnosis
ICD-9 codes decreased from 309 in 2002 to 266 per
100 000 population in 2005.19 The numbers of total
discharges and coronary revascularizations compared rea-
sonably well with estimates from the National Hospital
Discharge Survey, but the diagnoses of MI were not
specifically validated. An analysis of data from the National
Hospital Discharge Survey showed that the rate of hospital-
izations for MI using the first-listed diagnosis code increased
from 215 in 1979–-1981 to 342 per 100 000 population in
1985–-1987, remained relatively level until 1996, and then
declined to 242 per 100 000 population in 2003–-2005.20
No validation of discharge diagnoses was done. The rate of


























































































Figure 1. Age-adjusted mortality rates from CHD for adults aged ≥25 years, United States. Results were generated with WONDER using the
Compressed Mortality File of the National Vital Statistics System. For the period 1979–1999, International Classification of Diseases 9 codes
410-414 and 429.2 were used. For 2000–2009, International Classification of Diseases codes I20-O25 were used. Results were age-adjusted to
the projected year 2000 US population. CHD indicates coronary heart disease.
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among Medicare fee-for-service beneficiaries dropped from
1131 in 2002 to 866 per 100 000 person-years in 2007.21
Discharge diagnoses were not validated. An analysis of data
from the National Inpatient Sample of the Healthcare Cost
and Utilization Project from 2001 to 2007 found that the
rate of hospitalization from MI based on the principal
diagnosis dropped from 314 to 222 per 100 000 population,
and decreases were observed in most demographic sub-
groups.22 The validity of the discharge diagnoses over time
remained untested in this data set. However, these studies
were not able to identify incident CHD or to examine the
impact of changes in diagnostic criteria for MI on hospital-
ization rates. Furthermore, validation of hospitalizations for
MI diagnostic codes has generally not been done in these
studies.
Case-Fatality
Several measures of case-fatality rates can be conceptualized
in terms of time frame: in-hospital mortality, 28- or 30-day





























































































Figure 2. Age-adjusted mortality rates from CHD for adults aged ≥25 years, by race and gender, United States. Results were generated with
WONDER using the Compressed Mortality File of the National Vital Statistics System. For the period 1979–1999, International Classification of
Diseases 9 codes 410-414 and 429.2 were used. For 2000–2009, International Classification of Diseases codes I20-O25 were used. Results
were age-adjusted to the projected year 2000 US population. AAF indicates African-American females; AAM, African-American males; CHD,
coronary heart disease; OF, other females; OM, other males; WF, white females; WM, white men.
Table 1. Large Studies of Trends in Hospitalization Rates for Myocardial Infarction in the United States







Nallamothu19 Acute Care Tracker Database 2002–2005 309 to 266 Principal No
Fang20 National Hospital Discharge Survey 1979–1981 to 1985–1987 215 to 342 Principal No
1985–1987 to 2003–2005 342 to 242
Chen21 Medicare fee-for-service beneficiaries 2002–2007 1131 to 866 Principal No
Wang22 National inpatient sample 2001–2007 314 to 222 Principal No
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Numerous publications have documented improvements in
the in-hospital or short-term case-fatality rate.7,11,18,20,23–
26,28–34,38,39 The first indications that CHD case-fatality rates
had improved emerged during the 1960s.7 Since then, case-
fatality rates have generally improved steadily. Fewer data are
available concerning the long-term survival of people who
develop CHD. In Rochester, MN, the 5-year mortality rate from
1965–1969 to 1970–1975 decreased from 40.0% to 34.0%.7
An early report from the Worcester Heart Attack Study failed
to observe improved post-discharge long-term survival in
patients who sustained an MI in 1975, 1978, or 1981.40 A
subsequent analysis of data from this study again failed to
find improvements in 1-, 2-, and 5-year survival rates for
patients who were discharged during 1975–1978, 1981–
1984, 1986–1988, and 1990–1991.27 More recently, 1-year
survival for patients discharged with an ST-segment elevation
MI (STEMI) during 2003 and 2005 and for patients discharged
with non-ST-segment MI (NSTEMI) during 2005 improved,35
and 1- and 2-year mortality rates from 2001 to 2006
decreased from 17.1% to 12.7% and 25.6% to 18.6%,
respectively.37 In the Minnesota Heart Survey, 3-year mortal-
ity after hospitalization for MI decreased from 21% in 1985 to
18% in 1990 among men and from 29% to 24% among
women.18 Among Medicare beneficiaries, 1-year mortality
after a MI decreased from 40.2% in 1984 to 34.5% in 2003.30
In the Framingham Study, 1- and 5-year mortality among
adults who had an MI decreased by 65% and 64%, respec-
tively, during the period from 1960 to 1999.31
Prevalence
Broadly speaking, prevalence represents the net sum of input
(incidence) and outflow (mortality). Thus, information about
trends in CHD prevalence may shed light on the incidence of
CHD. Information about the prevalence of CHD comes from
national surveys, cohort studies, and regional surveillance
systems. National surveys like the National Health and
Nutrition Examination Survey (NHANES), National Health
Interview Survey (NHIS), and Behavioral Risk Factor Surveil-
lance System (BRFSS) use questionnaires to collect data to
estimate the prevalence of CHD. Because these systems rely
on self-reported information, such information is particularly
susceptible to various biases.
Several analyses of NHANES data have been undertaken.
Among NHANES participants aged 40 to 74 years, estimates
of the prevalence of self-reported MI were 6.3% during 1971–
1975, 5.6% during 1976–1980, and 5.7% during 1988–
1994.41 Among adults aged 35 to 54 years who participated
in NHANES, the prevalence of self-reported MI was 2.5%
during 1988–1994 and 2.2% during 1999–2004 among men
and 0.7% during 1988–1994 and 1.0% during 1999–2004
among women.42 Analysis of NHANES data by the National
Heart, Lung, and Blood Institute showed that the prevalence
of self-reported MI has declined from 1971–1975 to 2005–
2008 most clearly among whites and among men.6
To examine the recent trend in CHD prevalence, we used
NHANES data of adults aged ≥20 years from 1999 to 2012
(Table 3).43 CHD was defined as ever having been told by a
doctor or other health professional that the participant had
CHD, angina pectoris, or a heart attack. The unadjusted
prevalence showed little change during the 10-year period.
After adjustment for age, the prevalence of CHD increased
from 6.3% during 1999–2000 to 6.9% during 2003–2004 and
then decreased to 5.2% during 2009–2012, and the overall
trend showed a decrease (P for linear trend=0.001). Further-
more, decreases in the age-adjusted prevalence of self-
reported CHD were noted for men, women, whites, African
Americans, adults who had not completed high school or with
education beyond high school, adults without diagnosed
diabetes, and adults with a body mass index <30 kg/m2.
Based on data from the NHIS from 1980 to 1989, the
age-adjusted prevalence of self-reported CHD among US
adults aged 45 to 84 years varied between 2.2% and 2.6%
with no clear trend.44 Recent data from the BRFSS showed
that the prevalence of self-reported CHD declined from 6.7%
in 2006 to 6.0% in 2010 in adult populations aged
≥18 years.45 Declines were noted in all age groups, men
and women, all education groups, and among whites and
Hispanics but not among blacks, Asians or Native Hawai-
ians/Other Pacific Islanders, and American Indians or Alaska
Natives.
In several NHANES, electrocardiograms (ECGs) were
administered to adults aged 40 to 74 years. However, recent
NHANES have not included this component. The percentages
of adults with possible or probable ECG-defined MI were 3.6%
during 1971–1975, 3.4% during 1976–1980, and 2.4% during
1988–1994.41
Among successive groups of Framingham Study partici-
pants who were aged 55 to 64 years in 1953, 1963, and
1973, the prevalence of CHD among men increased from
10.2% in 1953 to 15.9% in 1973 (P=0.003) and that among
women from 5.5% in 1953 to 6.9% in 1973 (P=0.250).46 CHD
was defined as MI, coronary insufficiency, angina pectoris,
and sudden and non-sudden death from CHD.
Period prevalence of MI (hospitalization for MI or an out-of-
hospital death due to MI) in the Pee Dee area of South
Carolina decreased from 642 per 100 000 population in 1978
to 469 per 100 000 population in 1985.26 This overall trend
reflected a significant decrease among white men, nonsignif-
icant decreases among black men and women, and a
nonsignificant increase among white women.
A series of autopsy studies from Olmsted County, Minne-
sota provide an interesting perspective on the trend in the
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Table 3. Unadjusted and Age-Adjusted Prevalence (%, SE) of Self-Reported CHD Among Adults Aged ≥20 Years, National Health
and Nutrition Examination Survey 1999–2012
1999–2000 2001–2002 2003–2004 2005–2006 2007–2008 2009–2010 2011–2012 P Linear Trend
Unadjusted results
Total 5.8 (0.4) 5.9 (0.5) 6.8 (0.8) 6.1 (0.5) 5.6 (0.3) 5.5 (0.4) 5.4 (0.4) 0.165
Age, y
20 to 44 1.0 (0.3) 1.0 (0.2) 0.7 (0.3) 1.1 (0.3) 0.8 (0.2) 1.0 (0.3) 1.0 (0.3) 0.996
45 to 54 4.9 (0.9) 3.7 (0.8) 4.3 (0.8) 4.2 (0.6) 3.7 (0.6) 4.0 (0.6) 2.9 (0.8) 0.154
55 to 64 13.2 (1.5) 11.4 (2.5) 11.9 (1.9) 8.9 (1.6) 8.2 (1.1) 9.2 (1.0) 7.0 (0.8) 0.001
65+ 18.3 (1.3) 21.6 (1.9) 23.9 (2.2) 20.4 (1.2) 19.2 (1.4) 16.3 (1.0) 17.9 (1.1) 0.022
Gender
Men 7.3 (0.8) 6.8 (0.7) 7.8 (1.0) 7.1 (0.6) 7.0 (0.5) 7.3 (0.6) 6.5 (0.6) 0.529
Women 4.5 (0.5) 5.0 (0.6) 5.8 (0.7) 5.1 (0.6) 4.3 (0.3) 3.9 (0.4) 4.4 (0.4) 0.105
Race or ethnicity
Whites 6.7 (0.4) 6.7 (0.6) 7.7 (0.8) 6.9 (0.6) 6.1 (0.5) 6.4 (0.5) 6.2 (0.6) 0.177
African Americans 4.0 (0.6) 5.8 (0.9) 4.7 (0.6) 5.9 (0.7) 4.4 (0.7) 4.7 (0.7) 4.4 (0.4) 0.668
Mexican Americans 2.6 (0.3) 2.6 (0.5) 2.8 (0.6) 3.1 (0.4) 3.1 (0.4) 3.7 (0.7) 2.6 (0.8) 0.414
Other 4.3 (0.5) 2.8 (0.7) 5.4 (1.9) 2.3 (0.7) 5.4 (0.8) 3.1 (0.6) 4.1 (0.6) 0.991
Education
<High school 8.2 (0.6) 10.3 (1.0) 10.8 (1.9) 10.6 (1.1) 8.4 (0.5) 8.3 (1.0) 8.0 (0.9) 0.144
High school graduate
or equivalent
7.0 (0.7) 6.0 (0.8) 7.1 (1.2) 6.4 (1.1) 6.2 (0.7) 7.1 (0.8) 7.0 (1.3) 0.806
>High school 4.0 (0.5) 4.2 (0.4) 5.3 (0.5) 4.6 (0.4) 4.3 (0.3) 4.1 (0.4) 4.2 (0.5) 0.733
Diagnosed diabetes
Yes 21.4 (3.2) 19.2 (3.0) 21.4 (3.0) 21.0 (1.8) 20.0 (1.7) 17.6 (1.9) 19.3 (1.9) 0.425
No 4.7 (0.4) 4.9 (0.4) 5.4 (0.5) 4.7 (0.4) 4.1 (0.3) 4.3 (0.3) 3.8 (0.4) 0.014
BMI, kg/m2
<25 3.9 (0.3) 3.3 (0.5) 5.5 (0.8) 3.4 (0.5) 4.1 (0.4) 3.5 (0.6) 3.5 (0.6) 0.368
25 to <30 6.7 (0.7) 5.7 (0.8) 7.2 (0.8) 7.1 (0.7) 5.3 (0.5) 4.9 (0.5) 5.2 (0.7) 0.034
≥30 7.2 (0.7) 8.0 (1.0) 8.0 (0.9) 7.2 (0.6) 7.0 (0.8) 8.0 (0.6) 7.3 (0.5) 0.873
Age-adjusted results
Total 6.3 (0.4) 6.4 (0.5) 6.9 (0.6) 6.1 (0.3) 5.5 (0.3) 5.3 (0.3) 5.2 (0.3) 0.001
Gender
Men 8.4 (0.9) 7.9 (0.7) 8.4 (0.9) 7.7 (0.5) 7.4 (0.5) 7.4 (0.4) 6.6 (0.5) 0.043
Women 4.6 (0.5) 5.2 (0.5) 5.6 (0.7) 4.9 (0.6) 4.0 (0.3) 3.7 (0.4) 4.0 (0.3) 0.003
Race or ethnicity
Whites 6.6 (0.4) 6.5 (0.6) 7.0 (0.7) 6.2 (0.4) 5.4 (0.4) 5.5 (0.4) 5.2 (0.4) 0.001
African Americans 5.4 (0.9) 7.5 (0.9) 5.6 (0.7) 7.1 (0.7) 4.9 (0.7) 4.9 (0.5) 4.8 (0.4) 0.037
Mexican Americans 4.6 (0.5) 5.5 (0.7) 5.4 (0.5) 4.4 (0.4) 5.2 (0.6) 5.6 (0.7) 4.8 (1.4) 0.908
Other 5.5 (0.9) 4.3 (0.8) 7.3 (2.5) 2.9 (0.8) 6.1 (0.7) 4.2 (0.8) 4.9 (0.7) 0.481
Education
<High school 7.3 (0.7) 9.1 (1.0) 8.8 (1.3) 9.1 (0.9) 7.4 (0.6) 7.0 (0.8) 6.3 (0.7) 0.040
High school graduate
or equivalent
7.2 (0.7) 6.3 (0.9) 6.8 (1.0) 5.6 (0.6) 5.7 (0.5) 6.5 (0.8) 6.1 (1.2) 0.404
>High school 5.5 (0.7) 5.4 (0.4) 6.5 (0.5) 5.5 (0.4) 4.8 (0.3) 4.3 (0.3) 4.5 (0.4) 0.008
Continued
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prevalence of CHD. Among adults aged >30 years, the
prevalence of “significant coronary disease” increased from
23% during 1950–1954 to 51% during 1975–1979 and the
prevalence of a MI scar ranged between 36% and 41%.47 A
subsequent autopsy study showed that the prevalence of
atherosclerosis declined among adults aged 20 to 59 years
(1979–1983: 38%; 1984–1989: 36%; 1990–1994: 27%; P for
trend=0.02) but not adults aged ≥60 years (1979–1983: 61%;
1984–1989: 70%; 1990–1994: 59%; P for trend=0.44) from
1979 to 1994.48 A more recent autopsy study among
residents aged 16 to 64 years from 1981 to 2004 showed
declines in the prevalence of any coronary artery disease and
mean grade.49
Risk Factors
Impressive changes in major risk factors for CHD have
occurred since the 1960s when national data about many of
these risk factors first became available. The per capita
cigarette consumption in the United States increased tre-
mendously from 1900 into the 1960s. Subsequent to the first
Surgeon General’s Report in 1964, cigarette consumption
started to decline and has reached levels last seen during the
1930s.50 In concert, the prevalence of smoking has
decreased precipitously from 42.4% in 1965 to 19.3% in
2010.51 Furthermore, the exposure to second-hand tobacco
smoke has also declined.52
Concentrations of total cholesterol, non-high-density lipo-
protein cholesterol, and low-density lipoprotein cholesterol
have decreased. Among adults aged 20 to 74 years, mean
concentrations of total cholesterol were 222 mg/dL during
1960–1962, 216 mg/dL during 1971–1975, 215 mg/dL
during 1976–1980, 204 mg/dL during 1988–1994, and
203 mg/dL during 1999–2002.53 Among adults aged
≥20 years, mean concentrations of total cholesterol were
206 mg/dL during 1988–1994, 203 mg/dL during 1999–
2002, and 196 mg/dL during 2007–2010; mean concentra-
tions of high-density lipoprotein cholesterol were 50.7 mg/dL
during 1988–1994, 51.3 mg/dL during 1999–2002, and
52.5 mg/dL during 2007–2010; mean concentrations of non-
high-density lipoprotein cholesterol were 155 mg/dL during
1988–1994, 152 mg/dL during 1999–2002, and 144 mg/dL
during 2007–2010; and mean concentrations of low-density
lipoprotein cholesterol were 129 mg/dL during 1988–1994,
123 mg/dL during 1999–2002, and 116 mg/dL during
2007–2010.54 In addition, control of hypercholesterolemia
has also improved.55
The trend in hypertension has been more complicated.56–58
Among adults aged 18 to 74 years, the age-adjusted preva-
lence of hypertension was 29.7% during 1960–1962, 36.3%
during 1971–1974, 31.8% during 1976–1980.56 Among
adults aged ≥20 years, the age-adjusted prevalence of
hypertension was 29.6% during 1999–2000, 29.0% during
2001–2002, 30.7% during 2003–2004, 29.9% during 2005–
2006, 30.6% during 2007–2008, and 29.5% during 2009–
2010.58 Both publications used a similar definition of
hypertension (systolic blood pressure ≥140 mm Hg, diastolic
blood pressure ≥90 mm Hg, or use of antihypertensive
medication). Thus, the prevalence of hypertension has shown
little change since 1988–1994. However, control of hyper-
tension is improving.57–59 Of adults with hypertension, 33.2%
were controlled during 1999–2002 compared with 45.8%
during 2005–2008.59
National data sets provide few insights about the long-term
changes in physical activity. Analyses of data from the NHIS
show that 14.3% of adults aged ≥18 years in 1998, 15.0% in
2000, 19.1% in 2009, and 20.7% in 2010 met the 2008
Physical Activity Guidelines for Americans (both aerobic
activity [≥150 minutes/week of moderate-intensity, 75 min-
utes/week of vigorous-intensity aerobic physical activity, or
an equivalent combination of moderate-and vigorous-intensity
aerobic activity] and muscle- strengthening activities
[≥2 days/week of muscle-strengthening activities involving
all major muscle groups of moderate or high intensity]).60 This
apparent increase in leisure-time physical activity may have
Table 3. Continued
1999–2000 2001–2002 2003–2004 2005–2006 2007–2008 2009–2010 2011–2012 P Linear Trend
Diagnosed diabetes
Yes 14.3 (2.8) 13.6 (3.1) 13.1 (2.0) 12.0 (1.3) 12.2 (1.4) 9.6 (1.2) 11.6 (1.6) 0.150
No 5.6 (0.4) 5.7 (0.4) 6.0 (0.5) 5.2 (0.4) 4.5 (0.3) 4.6 (0.3) 4.1 (0.3) <0.001
BMI, kg/m2
<25 5.1 (0.4) 4.5 (0.6) 6.3 (0.8) 3.7 (0.5) 4.6 (0.4) 3.9 (0.5) 3.6 (0.4) 0.003
25 to <30 6.8 (0.7) 5.9 (0.7) 6.5 (0.7) 6.7 (0.5) 4.9 (0.4) 4.5 (0.4) 4.8 (0.5) 0.002
≥30 7.1 (0.8) 8.7 (0.9) 8.2 (0.9) 7.1 (0.4) 6.7 (0.8) 7.3 (0.5) 6.8 (0.4) 0.151
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been counterbalanced by unfavorable trends in energy
expenditure at work and sedentary behavior. From 1960–
1962 to 2003–2006, estimated mean daily energy expendi-
ture at work among men and women declined by more than
100 calories.61 Sedentary behavior as exemplified by screen
time (the amount of time that people spend watching
television and videos, playing video games, or using a
computer) has increased nationally.62
Weight and height have been measured in national surveys
in the United States since 1960–1962. Among adults aged 20
to 74 years, the prevalence of obesity (body mass index
≥30 kg/m2) was 13.4% during 1960–1962, 14.5% during
1971–1974, 15.0% during 1976–1980, 23.3% during 1988–
1994, and 30.9% during 1999–2000.63 Among adults aged
≥20 years, the prevalence of obesity (body mass index
≥30 kg/m2) was 30.5% during 1999–2000, 30.6% during
2001–2002, 32.2% during 2003–2004, 34.3% during 2005–
2006, and 33.8% during 2007–2008, and 35.7% during 2009–
2010.64,65 Abdominal obesity has also increased since 1988–
1994.66,67
In the wake of the stark rise in obesity, the prevalence of
diabetes has increased substantially since 1976–1980. Using
1985 WHO criteria, the prevalence of diabetes among adults
aged 40 to 74 years was 11.4% during 1976–1980 and 14.3%
during 1988–1994.68 Using 2008 ADA criteria, the prevalence
of diabetes was 15.3% during 1988–1994 and 17.5% during
2005–2006.69
Predicted CHD Risk
Starting with the Framingham Risk Score,70 multiple CHD risk
equations have been developed to estimate the risk of
developing incident CHD over a defined period, generally
10 years. Because these risk equations integrate the effects
of key risk factors for CHD, trends in the predicted risk for
CHD may correlate with trends in incident CHD. Using risk
equations contained in the Adult Treatment Panel III report,
little change in predicted 10-year risk for CHD was observed
from the period 1988–1994 to 1999–2002 among US
adults.71 During 1988–1994, 76.5% of adults had a predicted
10-year risk of <10%, 11.2% had a predicted 10-year risk of
10% to 20%, and 12.3% had a predicted 10-year risk of >20%.
During 1999–2002, these percentages were 75.6%, 11.4%,
and 13.0%, respectively. A subsequent analysis of national
data showed that mean predicted 10-year risk calculated
using the Framingham Risk Score for CHD decreased from
10.0% during 1976–1980 to 7.9% during 1988-1994
(P<0.001) and decreased from 7.9% during 1988–1994 to
7.4% during 1999-2004 (P<0.001).72 The results from the
latter study support the thesis of a decline in the incidence of
CHD. A more recent analysis of NHANES data showed a
continuing decline in predicted 10-year risk from 1999–2000
to 2009–2010.73
Incidence
Because incident CHD can manifest itself in different clinical
presentations, measuring incident CHD can be challenging. A
person may experience the first signs of CHD as angina
pectoris and be treated on an outpatient basis. Another
person may experience an MI as the first sign of CHD and be
hospitalized. Someone else may die of sudden cardiac death.
Thus, providing an integrated picture of all these possible first
occurrences of CHD would require a system that is able to
capture the spectrum of disease expression. However, such a
system does not currently exist at the national level. Because
national data about incident CHD are not available, our
current knowledge of the true incidence of CHD in the United
States comes from an amalgam of community surveillance
(Table 4), cohort studies (Table 5), and health care delivery
systems. Each of these sources of information has, to a
variable degree, limitations that may include time frames,
geographic coverage, and generalizability of the study popu-
lations.
Community surveillance
One of the earliest studies to examine trends in the incidence
of CHD emanated from Rochester, Minnesota.7,74 The age-
and sex-adjusted rates (per 100 000) of CHD incidence
comprising angina pectoris, MI, and sudden unexpected death
were 589 during 1950–1954, 699 during 1955–1959, 589
during 1960–1964, 571 during 1965–1969, and 572 during
1970–1974, 538 during 1975–1978, and 559 during 1979–
1982. The rate among men generally decreased, whereas the
rate among women increased slightly. The age-adjusted rate
(per 100 000) of sudden unexpected death decreased from
126 during 1950–1954 to 73 during 1979–1982. Rates of
angina pectoris decreased from 240 to 213, whereas rates of
MI increased from 222 to 255 during the same period.
A more recent study from Olmsted County, Minnesota
showed that the age- and sex-adjusted rate (per 100 000) of
hospitalizations for incident MI from 1987 to 2006 changed
from 186 to 180 (P=0.171).34 When MI hospitalizations were
restricted to those that used creatine kinase/creatine kinase-
MB but not troponin for the diagnosis of MI, a significant
decrease in the rate from 186 to 141 was observed.
Furthermore, rates of STEMI declined significantly by 41%
when troponin was considered or 44% when troponin was
excluded. However, rates of incident NSTEMI increased by
49%. An interesting aspect of this study is that measurements
of creatine kinase/creatine kinase-MB continued to be
administered from 2000 on as troponin was being ushered
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Table 4. Community Studies of Incident Coronary Heart Disease or Sudden Death in the United States
Reference Study CHD Event Period Group Rates or Percent Change
Elveback7,74 Rochester,
Minnesota
Incident CHD (angina, MI, sudden
unexpected death): medical,








Sudden death: death certificates 1970–1978 Men 311 to 244/100 000 population‡
Women 96 to 70/100 000 population‡
Goldberg25 Worcester Heart
Attack Study
MI. Review of medical records: history,
enzymes, ECG. Autopsy records
1975–1984 Total 255 to 186/100 000 population‡
Goldberg75 Worcester Heart
Attack Study
MI. Review of medical records: history,
enzymes, ECG. Autopsy records
1975–1988 Men 323 to 240/100 000 population‡
Women 176 to 137/100 000 population‡
McGovern18 Minnesota Heart
Survey
Acute CHD: ICD-9 410-411. Hospital
records were abstracted; computer-
based algorithm
1985 to 1990 Men 315 to 298/100 000 population†
Women 111 to 107/100 000 population†
Goff76 Corpus Christi
Heart Project
MI hospitalizations. Review of medical


























MI hospitalizations. Hospital records
were abstracted (symptoms, history,
enzymes, ECG); computer-based
algorithm
1987–1994 Women 1.9 to 1.8/1000 persons†
Men 4.1 to 4.1/1000 persons†
Cobb77 Seattle,
Washington
Cardiac arrests receiving advanced life
support. Medical incident reports
supplemented with information from




Total 1.39 to 0.91/1000 population*
Men 2.15 to 1.24/1000 population*
Women 0.68 to 0.61/1000 population†
Cardiac arrest with ventricular fibrillation
as first recorded rhythm
Total 0.85 to 0.38/1000 population*
Men 1.39 to 0.60/1000 population*
Women 0.35 to 0.17/1000 population*
Polentini78 Milwaukee,
Wisconsin













MI. Review of medical records: cardiac
pain, biomarkers (CK, CK-MB, troponin),
ECG. Computer-based algorithm
1987–2006 All MI 186 to 180/100 000 population†
Continued
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in, thus allowing an evaluation of the impact of changing
diagnostic criteria on trends in MI incidence.
From 1970 to 1978, out-of-hospital mortality rates from
CHD in Minneapolis and St. Paul, Minnesota declined by 43%
among men and by 40% among women.23 Another study in
Minneapolis and St. Paul found that the age-adjusted
hospitalization rates for first MI declined by 5% among men
and 4% among women from 1985 to 1990 based on ICD-9-CM
codes of 410 and 411 obtained from 31 hospitals in 1985 and
25 hospitals in 1990 among patients aged 30 to 74 years.18
These changes were not statistically significant.
From 1988 to 1992, the age-adjusted incidence rates of
hospitalized MI in the Corpus Christi Heart Project
decreased significantly among Mexican-American women.76
Nonsignificant reductions were reported for white women
and Mexican-American men, and little change was reported
for white men.
In Seattle, the age- and sex-adjusted incidence rates of
cardiac arrest with ventricular fibrillation from 1980 to 2000
declined by 56%, and the incidence of all treated arrests
declined by 34%.77 Declines in the incidence rates of cardiac
arrest with ventricular fibrillation were similar for men and
women, but the decline in the incidence rates of all treated
arrests in men exceeded that in women.
As part of the ARIC study, surveillance of hospital
admissions for MI among residents aged 35 to 74 years
Table 4. Continued
Reference Study CHD Event Period Group Rates or Percent Change
CK/CK-MB MI 186 to 141/100 000 population*
McManus35 Worcester Heart
Attack Study
MI hospitalizations. Review of medical
records: history, enzymes, ECG
1997–2005 STEMI 121 to 77/100 000 population*





MI hospitalizations. Hospital records






White men 4.3%/year ↓*
White women 3.8%/year ↓*
Black men 1.5%/year ↓*




White men 5.4%/year ↓*
White women 4.4%/year ↓*
Black men 2.2%/year ↓*




White men 4.8%/year ↓*
White women 4.5%/year ↓*
Black men 2.0%/year ↓*
Black women 3.9%/year ↓*
ECG indicates electrocardiograms; MI, myocardial infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction.
*Statistically significant change.
†Change was not statistically significant.
‡Statistical significance of change was not reported.
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was conducted among adults aged 35-74 years in 4
communities (Forsyth County, NC; Jackson, MS; Minneapolis
suburbs, MN; Washington County, MD) from 1987 to
1994.11 Hospital discharges meeting certain ICD-9-CM
codes from 28 hospitals were reviewed, and a computer-
ized algorithm assigned a diagnosis using information on
symptoms, cardiac enzymes, and ECGs collected by study
personnel from medical records. A total of 11 869 hospi-
talizations for MI were estimated. The age-adjusted rate of
hospitalizations for incident MI in women was 1.9 per 1000
population in 1987 and 1.8 per 1000 population in 1994,
whereas the rate in men remained unchanged at 4.1 per
1000 population. The average annual rate of change during
the study period was +2.9% among black men, +7.4%
among black women, 2.5% among white women, and
0.3% among white men. Out-of-hospital mortality attrib-
uted to CHD declined by 3.6% per year.
More recently, updated results of this surveillance system
in these 4 communities from 1987 to 2008 showed that the
age-adjusted rate of hospitalizations for incident MI
declined.38 The basic surveillance methodology remained
largely the same. Because this study covered a period that
saw profound changes in the use of diagnostic biomarkers
(the advent of troponin), the study authors made a number of
adjustments in their analytic strategy to account for these
changes. For this study, 30 985 hospitalizations for MI were
estimated. The age- and biomarker adjusted rate of hospital-
ization for a first MI changed by 4.3% (95% CI: 4.7, 3.8)
among white men, 3.8% (95% CI: 4.5, 3.1) among white
women, 1.5% (95% CI: 2.7, 0.4) among black men, and
2.9% (95% CI: 4.2, 1.5) among black women. Compared
to the period 1987–1996, the decline in the rates of
combined hospitalization for incident MI or fatal CHD during
1997–2008 accelerated. Declines were observed in the age-
and biomarker-adjusted rate of hospitalization for both STEMI
and NSTEMI. The authors noted that the patterns in rates
based only on ECG criteria and clinical history mirrored rates
that included biomarker data. Out-of-hospital mortality attrib-
uted to CHD declined by 5.6% per year among white men,
4.4% per year among white women, 2.7% among black men,
and 2.6% among black women. Declines in both sexes during
the period 1997–2008 far exceeded the declines during the
period from 1987 to 1996.
Surveillance of MI among residents of Worcester, Massa-
chusetts as part of the Worcester Heart Attack Study has
been conducted since 1975.25,27,32,75 Hospitalizations for MI
were identified, and medical records for these hospitalizations
were reviewed. Information about the clinical history, ECG
changes, and biomarker changes was abstracted to make a
determination of MI. Although the age-adjusted hospitaliza-
tion rates (per 100 000) for incident MI dropped from 277 in
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varied considerably.32 A subsequent investigation of trends in
incident hospitalizations for MI from 1997 to 2005 showed
that the incidence rate for STEMI was 121 in 1997, peaked in
1999 and then declined progressively to 77 through 2005.35
In contrast, the incidence rate of NSTEMI spiked in 2001 and
then declined reaching a level in 2005 (132) that was similar
to that in 1997 (126). From 1975 to 1988, out-of-hospital
mortality rates attributed to CHD declined by 60% among men
and 69% among women.75
In Milwaukee, the incidence (per 100 000) of treated
cardiac arrest with ventricular fibrillation or tachycardia as the
first recorded rhythm declined from 37.1 in 1992 to 19.4 in
2002.78 The incidence of all treated arrests was 82.8 in 1992
and 82.3 in 2002.
These community surveillance studies provide strong
evidence that incidence has decreased in those areas
although the onset of the decline varied by geographical
location with the earliest decline being observed in Olmsted
County, Minnesota. These well-conducted studies employed
standardized case-definitions for MI. Two of these studies also
carefully navigated the changing currents in diagnostic criteria
for MI. Nevertheless, a drawback of these studies remains
their narrow geographic focus.
Cohort studies
A study of male employees of Du Pont Company showed that
the age-adjusted incidence rate (per 1000) of first MI
decreased steadily from 3.19 during 1957–1959 to 2.29
during 1981–1983.24 Events were identified from insurance
claims and death certificates, and medical records were
reviewed.
In a cohort of 8006 men of Japanese ancestry living on
Oahu, the incidence of CHD increased from 1966 to 1978 and
then decreased through 1984.9 For the entire study period,
the estimated annual change in incidence was 0.4% (95% CI:
2.6%, +1.8%). Incident CHD events included CHD deaths
(ICD-8 codes 410-414 as the underlying or contributing cause
of death or sudden unexplained deaths within 1 hour of being
well) and nonfatal MI (ECG evidence and/or cardiac enzyme
changes).
An early analysis of data from the Framingham Heart Study
found that the incidence of CHD among 3 successive cohorts
of men and women aged 55-64 years did not change
significantly from 1953–1963 to 1973–1983.46 For men,
incidence rates (per 1,000) for CHD were 187 during 1953–
1963, 210 during 1963–1973, and 208 during 1973–1983 (P
trend=0.41), and incidence rates for MI were 103 during
1953–1963, 116 during 1963–1973, and 120 during 1973–
1983 (P trend=0.42). For women, incidence rates for CHD
were 131 during 1953–1963, 132 during 1963–1973, and
110 during 1973–1983 (P trend=0.41), and incidence rates
for MI were 38 during 1953–1963, 50 during 1963–1973, and
45 during 1973–1983 (P trend=0.38). CHD was defined as
MI, coronary insufficiency, angina pectoris, and sudden and
non-sudden death from CHD. MI was determined from serial
ECG changes and cardiac enzymes when they became
available.
In a subsequent analysis of data from the Framingham
Heart Study, 20-year incidence of CHD in 3 consecutive
cohorts of adults aged 50 to 59 years was examined.10 CHD
included MI, angina, sudden and non-sudden coronary death,
and coronary insufficiency. Among women, the incidence (per
1000) of CHD decreased significantly from 218 events in the
1950 cohort to 175 events in the 1970 cohort (P<0.05). In
contrast, the rate among men was 354 in the 1950 cohort
and 346 in the 1970 cohort.
Another analysis of data from the Framingham Heart Study
and Framingham Heart Study Offspring Cohort found that the
risk of sudden coronary death in adults without CHD or
congestive heart failure decreased by 39% from 1950–1969
to 1990–1999.80
More recently, data from the Framingham Heart Study and
Framingham Heart Study Offspring Cohort showed that the
incidence of MI had declined during successive decades
starting with 1960–1969 and ending with 1990–1999.31
Among 9824 participants aged 40 to 89 years, 941 MIs were
recorded of which 639 were defined on the basis of ECG
changes and 302 on the basis of biomarker changes. MIs
were identified by information obtained from study partici-
pants during follow-up examinations or mailings of update
questionnaires and evaluated with medical records. MIs were
divided into 2 groups: those with ischemic chest discomfort
and diagnostic ECG changes irrespective of diagnostic
biomarker changes (MI-ECG) and those with ischemic chest
discomfort and diagnostic biomarker changes without diag-
nostic ECG changes (MI-marker). Rates of incident MI-ECG
dropped by about half, whereas rates of incident MI-marker
doubled. Significant decreases in MI-ECG were noted for men
aged 50 to 59 years and 70 to 79 years as well as women
aged 70 to 79 years. In contrast, significant increases in ECG-
marker were noted for men aged 50 to 59 years and 70 to
79 years as well as women aged 70 to 79 years. The authors
concluded that much of the uncertainty in trends in the
incidence of MI may have been attributable to changes in
diagnostic criteria for MI.
Data from the Nurses’ Health Study that included 85 941
participants aged 34 to 59 years showed that the incidence of
CHD declined by 31% from 1980–1982 to 1992–1994.79 CHD
was defined as nonfatal MI or fatal coronary disease. The
former was determined from medical record review of MIs
reported by the study participants, and MI was defined using
World Health Organization criteria. Deaths were determined
from state vital records, the National Death Index, reports by
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next of kin, and the postal system. In all, 946 participants had
a nonfatal MI and 358 experienced death attributable to
coronary disease.
An analysis of data from the National Health and Nutrition
Examination Survey I Epidemiologic Follow-up Study from 1971
to 1992 showed that the age-adjusted incidence (per 10 000)
declined from 133.3 from 1971–1975 to 1982–1984 to 113.5
from 1982–1984 to 1992 for CHD and from 49.7 to 49.2,
respectively, for MI.28 The incidence of CHD declined signif-
icantly among white men (14.6%) and women (11.4%). The
relative decrease among black men (18.5%) was the largest
of the 4 groups but failed to reach statistical significance. The
decrease among black women (3.8%) was the smallest of any
of the 4 groups. The baseline cohort included 10 869
participants aged 35 to 74 years, and the follow-up cohort
included 9774 participants aged 35 to 74. Incident CHD was
defined as a death from CHD, a hospitalization for CHD, or a
nursing home stay with the ICD-9 codes of 410-414. Prevalent
CHD was excluded from the baseline cohort on the basis of
self-reported heart attack, heart failure, or stroke as well as the
use of medications used to treat heart disease.
The cohort studies provide valuable insights into trends of
incident CHD in their study populations, which range from
relatively specific populations such as employees of a
company to near representative samples of US adults. Thus,
generalizability of their findings to the national level is a prime
limitation. Also, the age range of participants of many cohort
studies is limited precluding an examination of trends in
incidence across the full adult lifespan. By examining the
experience of the participants who have been repeatedly
examined, a Hawthorne-type of effect could be introduced
into studies in that study participants may alter their
behaviors in response to their study participation. On the
other hand, cohort studies often use some of the best-
validated measures of incident CHD and yield information
over some of the longest time frames.
Health care delivery systems
The large health care delivery systems potentially represent
an important opportunity for conducting surveillance of CHD
in large segments of the US population. Drawing from the
administrative systems of Kaiser Permanente Northern Cal-
ifornia, investigators identified hospitalizations for MI from
1999 to 2008 using the ICD-9-CM code of 410 and divided
these into hospitalizations for STEMI (ICD-9-CM codes 410.0-
410.6, 410.8) and NSTEMI (410.7, 410.9).33 A total of 46 086
hospitalizations for incident MI among adults aged ≥30 years
were included in the analyses. The age- and sex-adjusted rate
(per 100 000 person-years) of hospitalizations for incident MI
were 274 in 1999 and 287 in 2000 and then progressively
declined to 208 through 2008. Rates of STEMI decreased
steadily throughout the study period from 133 to 50, but the
rates of NSTEMI increased until 2004 and began to decrease
in subsequent years. Validation studies were performed to
show that the positive predictive value for the STEMI and
NSTEMI coding algorithm did not materially change during the
study period.
Because health care delivery systems represent an impor-
tant source of health care and coverage, the databases and
expanding rich electronic medical records of these health
systems contain potentially valuable information about trends
in the incidence of CHD of their memberships. However,
information from these data systems is subject to several
considerations: data from these plans generally may not reach
back far in time, the need to validate electronic data sources
deserves careful consideration, and health care delivery
systems may not be fully representative of all relevant
populations (eg, uninsured persons).
Population surveys
Data from the National Health Interview Survey have been
analyzed to examine trends in the incidence of CHD.44
Participants who reported that they had CHD, angina pectoris,
myocardial infarction, or heart attack with an onset during the
12 months prior to their interview were considered to have
had an incident event. From 1980 to 1989, the age-adjusted
incidence per 1000 population ranged between 2.2 and 3.2
with no significant linear trend. Among white men, a nonlinear
trend was described with decreasing rates from 1986 to
1989. Among white women, a significant increase in the
incidence rate was observed.
Unrecognized MI
Some percentage of MIs are not diagnosed because patients
are asymptomatic, experience symptoms that do not prompt
them to seek medical care, or experience symptoms that may
be insufficiently characteristic of an MI and do not result in a
diagnostic evaluation.81 Thus, these MIs are typically recog-
nized when patients receive an ECG examination subsequent
to the MI. Such MIs are also referred to as silent,
asymptomatic, or undiagnosed MIs. The prevalence of unrec-
ognized MIs has been reported to range from 4.3% to
44%,81,82 and factors like the age and gender distribution of
study participants account in part for the wide range in
estimates. Little about possible trends in unrecognized MI is
known, and the impact of this category of MI on the trends in
incidence of MI is unclear. Despite clinical impressions that
persons with diabetes experience more painless MIs, it
remains uncertain whether the increased prevalence of
diabetes may have affected trends in unrecognized MI
because diabetes has not been shown to be an independent
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predictor of unrecognized MI.81 For cohort studies such as the
Framingham Heart Study that administer periodic ECGs,
unrecognized MIs should have been captured, and the trends
in incident CHD reported from such cohort studies should not
be biased by the exclusion of unrecognized MIs, although
Framingham included a selected patient sample that may not
be representative of the broader US population. The results
from other studies that rely on identifying patients with MI
who present for medical care could be biased depending on
the direction and strength of the trends in unrecognized MI.
Severity of MI
Successful primary prevention that reduces the incidence of
CHD may favorably shift the distribution of severity of MI.
Consequently, evidence of a change in the severity of MI may
provide indirect support for a reduction in the incidence of
CHD. Data from several studies suggest that the severity of
MIs has lessened.34,35,83–88 Initial reports from Worcester,
Massachusetts found that the incidence of cardiogenic shock
complicating an MI did not change significantly from 1975 to
1988 or from 1975 to 1997.83,84 A more recent report noted
that there was evidence of a decline in cardiogenic shock
from the late 1990s to 2005.87 A decline in the incidence of
STEMI but not NSTEMI in Worcester also suggests that the
severity of MI declined in that area.35 An initial report from
ARIC investigators yielded inconsistent evidence that the
severity of MIs had decreased from 1987 to 1994.85 However,
a subsequent report covering the period from 1987 to 2002
noted that the severity of MI had declined.88 An investigation
conducted in Olmsted County, Minnesota showed that the
severity of MI had decreased from 1983 to 1994.86 A more
recent study from 1987 to 2006 noted declines in the
proportion of MIs with Killip class 2-4 and with ST-segment
elevation.34 Furthermore, the decline in hospitalizations for
incident STEMI not paralleled by a similar decline in NSTEMI in
the Kaiser Permanente Northern California system argues for
a decline in the severity of MI.33 Because severity of an MI
reflects a complex mix of pathophysiologic underpinnings,
patient behavior in seeking medical care, comorbidities, and
medical care, studying temporal trends in severity is a
complicated endeavor.89,90 Nevertheless, the available evi-
dence suggests some degree of concordance between
improving trends in MI severity and incident CHD.
Summary and Closing Thoughts
Although a complete picture of the national trend in CHD
incidence in the United States remains elusive, the findings
from community-based studies, prospective studies, and
health care delivery systems reporting decreases in incidence
of CHD provide the most convincing evidence that the
national incidence of CHD may have declined. These findings
are buttressed by data showing declines in national rates of
death attributed to CHD, studies showing decreases in
sudden death and out-of hospital mortality associated with
MI, declines in hospitalizations for CHD, improving MI
severity, possible recent declines in prevalence of CHD,
declines in predicted 10-year risk, and favorable improve-
ments in the prevalence and control of some major CHD risk
factors. Although each of these pieces of information is an
imperfect reflection of incident CHD, in the aggregate they tell
an increasingly compelling story of the evolution of CHD
incidence in the United States. Declines in death from CHD
are potentially suggestive of declining CHD incidence if the
declines in case-fatality rates do not account for the entire
decrease in mortality.
Because the studies examining trends in CHD incidence
covered different time frames and were conducted in different
areas of the United States, pinpointing the exact time when
incidence started to decrease is difficult because the onset of
the start of any declines may have varied geographically.
Community surveillance studies have reported decreases in
incidence as early as the 1960s (Rochester, MN),7 during the
late 1980s (Corpus Christi Heart Project),76 1990s (ARIC),38
and 2000s (Worcester Heart Attack Study).32 Other studies
suggest that decreases in incidence occurred during the
1960s (Framingham Heart Study, the Du Pont Company),10,24
1970s (Framingham Heart Study),31 1980s (Nurses’ Health
Study, NHANES Epidemiologic Follow-up Study, Framingham
Heart Study),28,31,79 1990s (Framingham Heart Study, Nurses’
Health Study),31,79 and 2000s (Kaiser Permanente Northern
California).33
Three of the studies illustrate the difficulty in interpreting
surveillance data over long periods of time particularly when
changes in diagnostic criteria occur.31,34,38 The introduction
of troponin testing around the turn of the century marked an
important change in the diagnostic criteria for MI91 and
coincided with a shift in the ratio of STEMI to NSTEMI with
decreases in rates of STEMI and increases in rates of NSTEMI.
Furthermore, the advent of electron-beam computed tomog-
raphy and multi-detector computed tomography to detect
calcium in the walls of coronary arteries has led to earlier
identification of CHD.92 From a surveillance point of view,
these disruptive changes in diagnostic criteria emphasize the
importance of being able to disentangle the effects on such
changes on trend analyses.
Validation of incident CHD events enhances the credibility
of trends in CHD incidence. The majority of community
surveillance, cohort, and health care delivery system-based
studies included reviews of medical records searching for
clinical presentation, electrographic criteria, and cardiac
biomarkers to confirm the presence of CHD, although these
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validation efforts differed across studies and across time
periods as diagnostic criteria were also evolving.
Furthermore, observational studies suggest that an enor-
mous amount of CHD can yet be prevented by adopting
healthy behaviors or by optimizing behavioral and clinical risk
factors as exemplified by the AHA’s 7 cardiovascular health
metrics.93–99 In addition, initiatives such as the Million Hearts
Initiative, which aims to prevent 1 million heart attacks and
strokes by 2017 through a combination of clinical and
community actions, will, if successful, potentially hasten the
decline in the incidence of CHD.100,101
The data sources opening a window into race or ethnicity-
specific trends of CHD incidence are few. Data from the ARIC
study suggest that African-American men and women did
enjoy declining CHD incidence, but the decline among African
Americans manifested itself later than among whites and the
size of the decline was smaller than that of whites. These
results are corroborated by Medicare data and data from the
NIS also showing that the hospitalization rate for MI declined
more slowly among African Americans than among
whites.21,22 Gaps in evidence exist about the trends in CHD
incidence among other racial or ethnic groups such as
Hispanics and Asians. Given the rapidly evolving demographic
composition of the US population, data collection efforts to
shed light on the evolution of CHD in major and growing racial
and ethnic groups are needed. Perhaps, large health care
delivery systems and growing health system-based networks
are best suited to provide such results if their expanding
electronic medical record and other data systems capture
valid racial and ethnic designations and relevant clinical
outcomes of their memberships.
Efforts to establish community surveillance for CHD harken
back decades.102,103 A national system to monitor CHD
incidence has never been established, however, and this gap
has not gone unnoticed.104–107 As part of its recommenda-
tions, the Institute of Medicine highlighted the critical
importance of having data on the incidence of CVD and the
need for a system that would collect such data. The report
cited potential avenues such as the establishment of regis-
tries, the use of cohort studies, and the use of claims
and electronic medical record data to accomplish such a goal.
The development of a national system to monitor the trend in
the incidence of CHD would help to fill this current void in the
knowledge base of the epidemiology of CHD and provide
critical data to improve cardiovascular health of the US
population.
In conclusion, definitive data about national trends of
incident CHD in the United States currently are not available,
and, therefore, clues about these trends must be gleaned
from a variety of auxiliary data sources. Studies in different
parts of the country demonstrate improvements in the
incidence of CHD that may have commenced several decades
ago in some parts of the country, and an increasing number of
recent studies have described favorable trends during the first
decade of the 21st century. Taken together, these studies
yield encouraging but tentative signals that the incidence of
CHD in the United States may be waning. Bringing greater
clarity to this important topic of cardiovascular epidemiology
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